SPACInsider Logo
Biotech Acquisition Company (BIOT) Sells Sponsor Economics
by Nicholas Alan Clayton on 2022-12-23 at 7:33am

Biotech Acquisition Company (NASDAQ:BIOT) announced in an 8-K that it has agreed to sell most of its sponsor economics and undergo a management change.

An investor registered as IREEM LLC is purchasing 5,455,000 of Biotech’s promote shares (94.8%) and all 6,000,000 of its private placement warrants for $470,000 in total.

The outgoing team featured experience at a variety of European biotech venture capital firms and is to be replaced by primarily US-focused officers. The SPAC has not yet announced a new name or focus, but its incoming team suggests it could go in a number of different directions.

Laxmi Prasad Palaypu is to serve as CEO and chairman and also chairs New York-based boutique investment firm Interups (OTC:ITUP). Incoming CFO Jon Paul specializes in cannabis industry growth initiatives out of Las Vegas, Nevada. The SPAC’s new Board, meanwhile, features members ranging in experience from pharmaceutical research to steel production and municipal services.

Interups also specializes in deploying funds from Indian wealth management and retirement accounts into REIT and InvIT structures, but this may not be a hint at where the SPAC will look.

The new team’s first task will be getting as much of the SPAC’s estimated $232 million in trust through an extension vote. Biotech’s original transaction deadline is coming up on January 27, 2023 and it has already filed a pre-proxy for a vote without setting a date.

This proxy outlined a 10-month extension to October 27, 2023, and did not include a finalized amount for any proposed contribution to trust.

Recent Posts
by Marlena Haddad on 2023-03-31 at 5:15pm

Hudson Acquisition I Corp. (NASDAQ:HUDA) announced that it has signed a non-binding letter of intent (LOI) to combine with a pre-clinical-stage biotechnology company. The SPAC did not provide many details on the unnamed target, but disclosed that the biotech company is focused on developing intranasal preventives for major disease-causing respiratory viruses. As a condition to the target...

by Nicholas Alan Clayton on 2023-03-31 at 1:25pm

Heading into April, SPACs are to see eight sponsors and 11 de-SPAC’d companies freed from lock-ups and ready to trade. Most of these lock-up expirations are loaded into the final week of the month, but those hitting this milestone already next week include some of the more interesting transactions of the crop. In particular, MoonLake...

by Marlena Haddad on 2023-03-31 at 11:39am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News:  Shares of Digital World jump after Trump’s indictment, and pair of Delaware Chancery court decisions deny motions to dismiss SPAC shareholder’s fiduciary breach claims Trump-Tied SPAC’s Shares Jump After Historic New York Charge The...

by Kristi Marvin on 2023-03-30 at 7:37pm

Ares Acquisition Corporation II (NYSE:AACT) filed its S-1 yesterday afternoon for a $400 million IPO, marking the second SPAC to file for an IPO in March and the largest since December 20, 2021, when Gores Holdings X Inc. filed for a $725 million SPAC. Ares II intends to focus its search on an established target...

by Marlena Haddad on 2023-03-30 at 5:39pm

Latest SPAC Liquidations: TCV Acquisition Corp. TCV Acquisition Corp. (TCVA) to Liquidate on April 13 TCV Acquisition Corp. (Nasdaq: TCVA) announced that it intends to dissolve and liquidate. It will redeem all of the outstanding Class A ordinary shares that were included in its initial public offering at a per-share redemption price of approximately $10.24. As...

Privacy Policy|Terms Of Use
Copyright © 2023 SPACInsider, Inc. All Rights Reserved